Thirteen-week inhalation toxicity of carbon tetrachloride in rats and mice
- PMID: 17690517
- DOI: 10.1539/joh.49.249
Thirteen-week inhalation toxicity of carbon tetrachloride in rats and mice
Abstract
Subchronic toxicity of carbon tetrachloride (CCl4) was examined by inhalation exposure of F344 rats and BDF1 mice of both sexes to 0, 10, 30, 90, 270 or 810 ppm (v/v) CCl4 vapor for 13 wk (6 h/d and 5 d/wk). In the high exposure levels at 270 and 810 ppm, altered cell foci in the livers of both rats and mice, and fibrosis and cirrhosis in the rat liver were observed. Hematoxylin and eosin-stained altered cell foci of rats were recognized as glutathione-S-transferase placental form (GST-P) positive foci, which are preneoplastic lesions of hepatocarcinogenesis. The most sensitive endpoint of CCl4-induced toxicity was fatty change with large droplets in rats of both sexes and male mice, and cytoplasmic globules in male mice, as well as increased relative liver weight in male rats. Those endpoints were manifested at 10 ppm and the LOAEL was determined as 10 ppm for the hepatic endpoints in rats and mice. Enhanced cytolytic release of liver transaminases into plasma in rats and mice and its close association with hepatic collapse in mice were observed at medium and high levels of inhalation exposure. Both CCl4-induced hematotoxicity and nephrotoxicity were observed in both rats and mice, but those toxicities were manifested at higher exposure concentrations than hepatotoxicity. The LOAEL for the hepatic endpoint and the GST-P-stained altered cell foci provide relevant animal data for reconsidering the occupational exposure limit val1ue of 5 ppm for CCl4 and strengthen the evidence of CCl4-induced hepatocarcinogenicity which is used in its carcinogenicity classification.
Similar articles
-
Inhalation carcinogenicity and chronic toxicity of carbon tetrachloride in rats and mice.Inhal Toxicol. 2007 Oct;19(13):1089-103. doi: 10.1080/08958370701628770. Inhal Toxicol. 2007. PMID: 17957549
-
The inhalation exposure of carbon tetrachloride promote rat liver carcinogenesis in a medium-term liver bioassay.Toxicol Lett. 2008 Feb 15;176(3):207-14. doi: 10.1016/j.toxlet.2007.11.007. Epub 2007 Dec 3. Toxicol Lett. 2008. PMID: 18221844
-
Thirteen-week inhalation toxicity of 1,4-dioxane in rats.Inhal Toxicol. 2008 Aug;20(10):961-71. doi: 10.1080/08958370802105397. Inhal Toxicol. 2008. PMID: 18668411
-
Evaluation of the carcinogenicity of carbon tetrachloride.J Toxicol Environ Health B Crit Rev. 2023 Aug 18;26(6):342-370. doi: 10.1080/10937404.2023.2220147. Epub 2023 Jun 6. J Toxicol Environ Health B Crit Rev. 2023. PMID: 37282619 Review.
-
Methoxyflurane toxicity: historical determination and lessons for modern patient and occupational exposure.N Z Med J. 2021 Apr 30;134(1534):76-90. N Z Med J. 2021. PMID: 33927440 Review.
Cited by
-
The protective effect of infliximab against carbon tetrachloride-induced acute lung injury.Iran J Basic Med Sci. 2016 Jun;19(6):685-91. Iran J Basic Med Sci. 2016. PMID: 27482351 Free PMC article.
-
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.BMC Gastroenterol. 2010 Jul 9;10:79. doi: 10.1186/1471-230X-10-79. BMC Gastroenterol. 2010. PMID: 20618941 Free PMC article.
-
Benchmark Dose Modeling Approaches for Volatile Organic Chemicals Using a Novel Air-Liquid Interface In Vitro Exposure System.Toxicol Sci. 2022 Jun 28;188(1):88-107. doi: 10.1093/toxsci/kfac040. Toxicol Sci. 2022. PMID: 35426944 Free PMC article.
-
Mouse Models of Liver Parenchyma Injuries and Regeneration.Front Cell Dev Biol. 2022 May 5;10:903740. doi: 10.3389/fcell.2022.903740. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35721478 Free PMC article. Review.
-
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development.J Clin Transl Hepatol. 2015 Mar;3(1):53-66. doi: 10.14218/JCTH.2014.00035. Epub 2015 Mar 15. J Clin Transl Hepatol. 2015. PMID: 26357635 Free PMC article. Review.